Eyenuk recently received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically detects diabetic retinopathy. The company said this FDA clearance makes its system the only AI system that is FDA-cleared for use with multiple retinal cameras produced by different manufacturers.
Clearside Biomedical will use the Series C round to further clinical trials for its drug-device combination for diseases of the eye that cause blindness.
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
RetroSense Therapeutics, an Ann Arbor optogenetics startup, is developing an algae-based gene therapy that could restore functional sight in those with congenital vision loss disorders.
New Enterprise Associates just led a $35 million Series B round for British gene therapy startup NightstaRx, which is developing a viral vector-based therapy for inherited vision loss.
New data highlights the correlation between severe vision loss and poverty.
Kathy Bleitz suffers from a condition called Stargardt disease and has been legally blind since the age of 11. It’s an inherited degenerative disease that significantly reduces vision in the central part of the retina, but peripheral vision is sometimes retained. IFLScience explained how some new technology actually allowed Bleitz to see her new baby: […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Chris Downey lost his sight in 2008. The San Francisco architect had surgery to remove a brain tumor and went blind three days later. His TED talk is about experiencing the city before and after becoming blind. His ideas about how to design a city to make life easier for blind people are relevant for […]
Each year, a committee of Cleveland Clinic doctors asks hundreds of their colleagues to weigh in on which emerging healthcare technologies they think will help shape their practice over the next 12 months. Then, the committee evaluates nominations based on clinical impact, probability of commercial success, progress in commercialization and significant human interest, and produces […]
Technology that was initially meant to help soldiers and unmanned vehicles navigate uncharted territory is finding new life in a high-tech navigation device for people with impaired vision. Draper Laboratory, a not-for-profit research and development lab based in Cambridge, has partnered up with researchers at Alabama-based Auburn University to design a new navigation device that […]
The company commercializing what’s being called the world’s first bionic eye is reloading with some fresh capital before its U.S launch. Sylmar, California-based Second Sight Medical has its sights set on a $10.5 million round, according to a new U.S. Securities and Exchange Commission filing made this week. Company execs couldn’t comment on details of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.